PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA

被引:0
|
作者
BOSCH, RJLH
机构
关键词
DIHYDROTESTOSTERONE; STROMAL CELL; FIBROBLAST; STEM CELLS; ANDROGEN;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The pathogenesis of benign prostatic hyperplasia (BPH) remains largely unresolved. Three major theories have evolved over the years, each emphasizing a possible causative mechanism. The first theory, the dihydrotestosterone hypothesis, is based on the failure of BPH to develop in men castrated prior to puberty. The second, the embryonic reawakening theory, assumes a reawakening of the embryonic induction potential of prostatic stroma. The third, or stem cell theory, postulates the development of BPH through an increase in the number of stem cells or through an abnormal increase in clonal expansion of amplifying or transit cells. These mechanisms may act in concert.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 50 条
  • [1] ETIOLOGY OF BENIGN PROSTATIC HYPERPLASIA
    ISAACS, JT
    EUROPEAN UROLOGY, 1993, 25 : 6 - 9
  • [2] Genomic analysis of benign prostatic hyperplasia implicates cellular relandscaping in disease pathogenesis
    Middleton, Lance W.
    Shen, Zhewei
    Varma, Sushama
    Pollack, Anna S.
    Gong, Xue
    Zhu, Shirley
    Zhu, Chunfang
    Foley, Joseph W.
    Vennam, Sujay
    Sweeney, Robert T.
    Tu, Karen
    Biscocho, Jewison
    Eminaga, Okyaz
    Nolley, Rosalie
    Tibshirani, Robert
    Brooks, James D.
    West, Robert B.
    Pollack, Jonathan R.
    JCI INSIGHT, 2019, 4 (12)
  • [3] Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs
    Domoslawska-Wyderska, Anna
    Zdunczyk, Slawomir
    Rafalska, Agata
    REPRODUCTION IN DOMESTIC ANIMALS, 2024, 59 (05)
  • [4] PATHOPHYSIOLOGY OF BENIGN PROSTATIC HYPERPLASIA
    ALGABA, F
    EUROPEAN UROLOGY, 1993, 25 : 3 - 5
  • [5] Androgens and benign prostatic hyperplasia
    Mirone, V
    Fusco, F
    Verze, P
    Schulman, C
    Debruyne, F
    Imbimbo, C
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (04) : 410 - 417
  • [6] Dutasteride for the treatment of benign prostatic hyperplasia
    Wu, Christopher
    Kapoor, Anil
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1399 - 1408
  • [7] Pathophysiology and therapy of benign prostatic hyperplasia
    Sampson, Natalie
    Madersbacher, Stephan
    Berger, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (13-14) : 390 - 401
  • [8] Serum steroids in relation to benign prostatic hyperplasia
    Lagiou, P
    Mantzoros, CS
    Tzonou, A
    Signorello, LB
    Lipworth, L
    Trichopoulos, D
    ONCOLOGY, 1997, 54 (06) : 497 - 501
  • [9] Management of benign prostatic hyperplasia by family physicians
    Toguri, Allan
    Barkin, Jack
    CANADIAN JOURNAL OF UROLOGY, 2010, 17 : 26 - 34
  • [10] Recent advances in the diagnosis of benign prostatic hyperplasia
    Calvar, SIG
    Salcedo, JL
    Mangini, MAM
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2005, 39 (02): : 171 - 185